Raykov Rosty — SEC Form 4 filings
SEC reporting owner CIK 1468316. 54 Form 4 filings on record with FilingPulse; latest filed 2026-09-01.
Transaction summary — filings shown
Covers the 50 most recent of 54 filings on record, filed 2024-05-21 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 31 legs across 30 filings — 245,497 shares, $1,901,734 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 58.
- Largest priced transaction: sale of 10,000 shares @ $12.11 ($121,100) in FENNEC PHARMACEUTICALS INC., filed 2026-09-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| FENNEC PHARMACEUTICALS INC. (FENC) | — | 50 | — | 31 legs · 245,497 sh · $1,901,734 | 58 |
Form 4 filings — Raykov Rosty
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 2,778 @ $0 · Sale (S): 10,000 @ $12.11 | EDGAR |
| 2026-08-04 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Sale (S): 10,000 @ $9.58 | EDGAR |
| 2026-08-03 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 2,778 @ $0 | EDGAR |
| 2026-07-02 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 2,778 @ $0 · Option exercise (M): 15,597 @ $2.45 · Sale (S): 9,599 @ $10.41 · Option exercise (M): 15,597 (derivative) @ $2.45 | EDGAR |
| 2026-06-02 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 2,778 @ $0 · Option exercise (M): 15,597 @ $2.45 · Sale (S): 9,747 @ $9.62 · Option exercise (M): 15,597 (derivative) @ $2.45 | EDGAR |
| 2026-05-01 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Option exercise (M): 2,778 @ $0 · Option exercise (M): 15,598 @ $2.45 · Sale (S): 10,781 @ $6.47 · Option exercise (M): 15,598 (derivative) @ $2.45 | EDGAR |
| 2026-04-02 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 5,208 @ $0 · Option exercise (M): 15,598 @ $2.45 · Sale (S): 10,946 @ $6.31 · Option exercise (M): 15,598 (derivative) @ $2.45 | EDGAR |
| 2026-03-03 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Option exercise (M): 15,598 @ $2.45 · Sale (S): 10,079 @ $8.36 · Grant/award (A): 5,208 @ $0 · Option exercise (M): 15,598 (derivative) @ $2.45 | EDGAR |
| 2026-02-02 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 5,208 @ $0 | EDGAR |
| 2026-02-02 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Option exercise (M): 15,598 @ $2.45 · Sale (S): 10,349 @ $7.76 · Option exercise (M): 15,598 (derivative) @ $2.45 | EDGAR |
| 2026-01-05 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 5,208 @ $0 · Option exercise (M): 15,598 @ $2.45 · Sale (S): 10,312 @ $7.60 · Option exercise (M): 15,598 (derivative) @ $2.45 | EDGAR |
| 2025-12-05 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Sale (S): 10,000 @ $7.54 | EDGAR |
| 2025-12-02 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 5,208 @ $0 | EDGAR |
| 2025-11-06 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Sale (S): 10,000 @ $8.10 | EDGAR |
| 2025-11-03 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 5,208 @ $0 | EDGAR |
| 2025-10-08 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Option exercise (M): 4,609 @ $2.45 · Option exercise (M): 4,609 (derivative) @ $2.45 | EDGAR |
| 2025-10-06 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Sale (S): 10,000 @ $9.78 | EDGAR |
| 2025-10-01 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 5,208 @ $0 | EDGAR |
| 2025-09-08 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Option exercise (M): 36,207 @ $2.45 · Option exercise (M): 36,207 (derivative) @ $2.45 | EDGAR |
| 2025-09-04 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Sale (S): 10,000 @ $8.92 | EDGAR |
| 2025-09-02 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 5,208 @ $0 | EDGAR |
| 2025-08-05 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Sale (S): 10,000 @ $8.09 | EDGAR |
| 2025-08-01 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 5,208 @ $0 | EDGAR |
| 2025-07-07 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Sale (S): 10,000 @ $8.61 | EDGAR |
| 2025-07-01 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 5,208 @ $0 | EDGAR |
| 2025-06-06 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Sale (S): 10,000 @ $7.78 | EDGAR |
| 2025-06-02 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 5,208 @ $0 | EDGAR |
| 2025-05-19 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 33,334 @ $0 · Sale (S): 16,667 @ $6.78 | EDGAR |
| 2025-05-05 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Sale (S): 10,000 @ $6.31 | EDGAR |
| 2025-05-01 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 2,431 @ $0 | EDGAR |
| 2025-04-04 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Sale (S): 10,000 @ $5.25 | EDGAR |
| 2025-04-01 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 2,431 @ $0 | EDGAR |
| 2025-03-06 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Sale (S): 10,000 @ $6.79 | EDGAR |
| 2025-02-28 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 2,431 @ $0 | EDGAR |
| 2025-02-05 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Sale (S): 10,000 @ $6.66 | EDGAR |
| 2025-02-03 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 2,431 @ $0 | EDGAR |
| 2025-01-07 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Sale (S): 2,431 @ $6.08 · Sale (S): 7,569 @ $6.08 | EDGAR |
| 2025-01-03 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 2,431 @ $0 | EDGAR |
| 2024-12-23 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Option exercise (M): 25,000 @ $2.69 · Option exercise (M): 25,000 (derivative) @ $2.69 | EDGAR |
| 2024-12-05 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Sale (S): 796 @ $6.04 | EDGAR |
| 2024-12-04 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 2,431 @ $0 · Sale (S): 1,635 @ $6.13 | EDGAR |
| 2024-11-04 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 2,431 @ $0 · Sale (S): 2,431 @ $4.31 | EDGAR |
| 2024-10-01 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 2,431 @ $0 · Sale (S): 2,431 @ $4.94 | EDGAR |
| 2024-09-04 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 2,431 @ $0 · Sale (S): 2,431 @ $5.52 | EDGAR |
| 2024-08-27 | 4/A | FENNEC PHARMACEUTICALS INC. (FENC) | Gift (G): 50,000 @ $0 · Gift (G): 16,666 @ $0 · Gift (G): 28,372 @ $0 · Gift (G): 26,001 @ $0 | EDGAR |
| 2024-08-26 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Gift (G): 50,000 @ $0 · Gift (G): 16,666 @ $0 · Gift (G): 28,372 @ $0 | EDGAR |
| 2024-08-01 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 2,431 @ $0 · Sale (S): 2,431 @ $6.25 | EDGAR |
| 2024-07-02 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 2,431 @ $0 · Sale (S): 2,431 @ $6.13 | EDGAR |
| 2024-06-03 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 2,431 @ $0 · Sale (S): 2,431 @ $6.76 | EDGAR |
| 2024-05-21 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 200,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1468316 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →